Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the completed fremanezumab migraine study record, with detailed trial information, results measures, participating locations, and downloadable study documents, instead of an access-denied error.
    Difference
    100%
    Check dated 2026-11-10T15:18:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2; the study page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:20:56.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide notice about website terminology changes appears above the page, which continues to show a 403 error. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:13:30.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-13T16:50:24.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page no longer lists the Study Documents and related metadata such as the Statistical Analysis Plan and Study Protocol, along with associated provider and publications details. This reduces access to supplementary materials for the NCT02638103 HALO study while keeping the main study overview intact.
    Difference
    18%
    Check dated 2026-09-22T20:56:06.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0 on the page, signaling a newer version of the ClinicalTrials.gov page. This appears to reflect internal updates or maintenance rather than a substantive change to study details or publicly visible content.
    Difference
    0.0%
    Check dated 2026-09-15T21:35:39.000Z thumbnail image

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.